Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium

Does Robot-Assisted Approach to Radical Cystectomy Influence Surgeon Choice for Urinary Diversion?

“…Whether the incorporation of RA technology has pushed surgeons towards ICs in favor of CUD remains unclear, especially when there is underutilization of CUD even among open surgeons. In our 10-year experience, only 32 (8%) patients received CUD, which is lower than previously reported in RA series [5,12]. Although this difference may be attributed in part by the patient and disease characteristics, surgeon and technology could still have a contribution.…”

“…There has been increased utilization of robot-assisted radical cystectomy (RARC), since it provides superior perioperative outcomes, including reduced blood loss and hospital stay, without jeopardizing oncological outcomes [5,6]. Despite being employed for more than a decade now, it is still unknown whether a RobotAssisted (RA) approach to RC affects the surgeon inclination towards IC rather than CUD.…”

Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium

“…More interest has been spurred in robot-assisted radical cystectomy (RARC) aiming at improving perioperative outcomes, including blood loss, transfusion rates, hospital stay and recovery without compromising oncological efficacy 1,2 .…”

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

“…However, only 6/18 series (33%) reported a mean follow-up >36 months (21). On the other hand, Raza et al reported the long-term oncological outcomes using the IRCC database (11). At a median follow-up period of 67 months, OS and DFS rates were 50% and 67%, respectively (11).…”

“…Robot-assisted RC (RARC) has emerged as an alternative to ORC based on its possible reduction in estimated blood loss (EBL), blood transfusion rate, postoperative analgesia and quicker recovery of bowel function (9,10). The largest multi-institutional cohort study from the International Robotic Cystectomy Consortium (IRCC) reported that long-term oncological outcomes are similar to historical ORC data (1,11). On the other hand, measures of surgical quality for RARC include positive surgical margin (PSM) and lymph node (LN) yields, both of which have implications for oncological outcomes.…”